osteoarthrosisavocado / soybean unsaponifi ableshyaluronic acidостеоартрознеомыляемые соединения авокадо/соевых бобовгиалуроновая кислота1.1. Pereira D., Peleteiro B., Araújo J. et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage 2011;19(11):1270–85.Pereira D., Peleteiro B., Araújo J. et al. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. Osteoarthritis Cartilage 2011;19(11):1270–85.2.2. Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an update with relevance for clinical practiсe. Lancet 2011;377(9783):2115–26.Bijlsma J.W., Berenbaum F., Lafeber F.P. Osteoarthritis: an update with relevance for clinical practiсe. Lancet 2011;377(9783):2115–26.3.3. Pavelka K., Coste P., Geher P., Krejci G. Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months plus 2 months observation in patiens with osteoarthritis of the knee. Clin Rheumatol 2010;29(6):659–70.Pavelka K., Coste P., Geher P., Krejci G. Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months plus 2 months observation in patiens with osteoarthritis of the knee. Clin Rheumatol 2010;29(6):659–70.4.4. Boileau С., Martel-Pelletier J., Brunet J. et al. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes. Arthritis Rheum 2005;52(2):488–500.Boileau С., Martel-Pelletier J., Brunet J. et al. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes. Arthritis Rheum 2005;52(2):488–500.5.5. Scanzello C.R., Moskowitz N.K., Gibofsky A. The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis. Curr Rheumatol Rep 2008;10(1):49–56.Scanzello C.R., Moskowitz N.K., Gibofsky A. The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis. Curr Rheumatol Rep 2008;10(1):49–56.